Current estimate of costs of lung cancer screening in the United States.

Academic Article

Abstract

  • The United States Preventive Services Task Force recently endorsed the use of low-dose computed tomography for lung cancer screening in high-risk patients because of the potential to reduce deaths. Before implementation on a national level, it will be important to ensure that a safe, high-quality, and accessible service can be adequately provided. It will also be important to make sure that screening is cost-effective. This article summarizes the published analyses of lung cancer screening cost, provides a contemporary estimation of the annual cost of screening in the United States, and identifies areas for improvement in the future.
  • Authors

    Published In

    Keywords

  • Budget impact model, Cost-effectiveness, Early Lung Cancer Action Project (ELCAP), Low-dose computed tomography (LDCT), Lung cancer screening, National Lung Screening Trial (NLST), Cost-Benefit Analysis, Early Detection of Cancer, Health Expenditures, Humans, Lung Neoplasms, Mass Screening, Radiotherapy Dosage, Risk, Tomography, X-Ray Computed, United States
  • Digital Object Identifier (doi)

    Pubmed Id

  • 3917638
  • Author List

  • Mauchley DC; Mitchell JD
  • Start Page

  • 205
  • End Page

  • 215
  • Volume

  • 25
  • Issue

  • 2